Celularity Inc. (CELUW) Financials

CELUW Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 157.2 million 126.9 million
2023-09-30 157.2 million 126.9 million
2023-06-30 246.4 million 127.9 million
2023-03-31 362.4 million 206.8 million

CELUW Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -8.6 million 3.6 million
2023-09-30 -8.6 million 3.6 million
2023-06-30 -11.1 million 3.9 million
2023-03-31 -18.2 million 4.0 million

CELUW Net Income

No data available :(

CELUW Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 273000 - -
2023-09-30 - - 26.1 million
2023-06-30 3.1 million - 28.1 million
2023-03-31 8.5 million - 28.0 million

CELUW Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 188.3 million
2023-09-30 193.7 million
2023-06-30 176.6 million
2023-03-31 155.4 million

CELUW Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 228000 5.2 million - -
2023-09-30 228000 5.2 million 10.7 million -
2023-06-30 31000 8.6 million 12.8 million -
2023-03-31 3.2 million 17.0 million 13.9 million -

CELUW Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 3.8 million 3.6 million
2023-09-30 3.8 million 3.6 million
2023-06-30 2.9 million 1.0 million
2023-03-31 3.9 million 25.7 million

CELUW

Price: $0.01

52 week price:
0.01
0.05

Earnings Per Share: -0.87 USD

P/E Ratio: -0.04

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 4110

Market Capitalization: 89.8 million

Links: